Overall BWAY gets a fundamental rating of 6 out of 10. We evaluated BWAY against 186 industry peers in the Health Care Equipment & Supplies industry. While BWAY has a great health rating, its profitability is only average at the moment. An interesting combination arises when we look at growth and value: BWAY is growing strongly while it also seems undervalued. These ratings could make BWAY a good candidate for value and growth investing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.53% | ||
| ROE | 8.92% | ||
| ROIC | 2.75% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.78% | ||
| PM (TTM) | 12.73% | ||
| GM | 74.92% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.37 | ||
| Altman-Z | 6.08 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.19 | ||
| Quick Ratio | 3.02 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.32 | ||
| Fwd PE | 17.43 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.22 | ||
| EV/EBITDA | 77.74 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:BWAY (2/5/2026, 10:29:32 AM)
21.74
-0.41 (-1.85%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.32 | ||
| Fwd PE | 17.43 | ||
| P/S | 8.67 | ||
| P/FCF | 23.22 | ||
| P/OCF | 19.12 | ||
| P/B | 6.08 | ||
| P/tB | 6.08 | ||
| EV/EBITDA | 77.74 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.53% | ||
| ROE | 8.92% | ||
| ROCE | 3.26% | ||
| ROIC | 2.75% | ||
| ROICexc | 15.43% | ||
| ROICexgc | 15.43% | ||
| OM | 5.78% | ||
| PM (TTM) | 12.73% | ||
| GM | 74.92% | ||
| FCFM | 37.36% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.37 | ||
| Debt/EBITDA | 1.21 | ||
| Cap/Depr | 207.6% | ||
| Cap/Sales | 8.01% | ||
| Interest Coverage | 26.28 | ||
| Cash Conversion | 470.69% | ||
| Profit Quality | 293.55% | ||
| Current Ratio | 3.19 | ||
| Quick Ratio | 3.02 | ||
| Altman-Z | 6.08 |
ChartMill assigns a fundamental rating of 6 / 10 to BWAY.
ChartMill assigns a valuation rating of 7 / 10 to BRAINSWAY LTD-ADR (BWAY). This can be considered as Undervalued.
BRAINSWAY LTD-ADR (BWAY) has a profitability rating of 5 / 10.
The Earnings per Share (EPS) of BRAINSWAY LTD-ADR (BWAY) is expected to grow by 77.47% in the next year.